World Health Organization : Year 2002 ; Communicable Diseases and Emerging Infectious Diseases ; Tuberculosis, No. 2002.311: Second Meeting of the Global Working Group on TB/HIV

By Thaddee Buzingo, Dr.

Book Id: WPLBN0000215763
Format Type: PDF eBook:
File Size: 0.2 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 2002 ; Communicable Diseases and Emerging Infectious Diseases ; Tuberculosis, No. 2002.311: Second Meeting of the Global Working Group on TB/HIV
Author:	Thaddee Buzingo, Dr.
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Buzingo, Dr, B. T. (n.d.). World Health Organization : Year 2002 ; Communicable Diseases and Emerging Infectious Diseases ; Tuberculosis, No. 2002.311. Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
Effective action against TB/HIV coinfection is overdue. However, a number of important recent developments have created new opportunities for progress to be made, employing experience already gained and putting into practice new guidelines and recommendations. The Global Working Group on TB/HIV (the WG) was established under the auspices of the Global Stop TB Partnership and held its first meeting in April 2001. The meeting highlighted the severity of the dual TB/HIV epidemic and the need to step up action against it. The ProTEST approach to addressing TB/HIV was discussed, and initial experiences with pilot ProTEST projects were shared. This first meeting also reviewed and endorsed the WHO Strategic Framework to Decrease the Burden of TB/HIV.

Table of Contents
Contents Glossary of abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5 Executive summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7 Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11 1 Background and objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11 1.1 The Global Working Group on TB/HIV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11 1.2 New developments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11 1.3 Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12 2 Updates: presentations from national and global bodies . .13 2.1 Country presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13 2.2 Presentations from international organizations . . . . . . . . . . . . . . . . . . . . . . . . . . .15 3 Progress with joint TB/HIV interventions . . . . . . . . . . . . . . . . . . . .21 3.1 ProTEST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21 3.2 Country experiences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22 4 Endorsement of the draft WHO guidelines for implementing collaborative TB and HIV programme activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31 4.1 Presentation of the guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31 4.2 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32 5 Anti-retroviral treatment (ART) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33 5.1 Experience in Brazil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33 5.2 Experience in Malawi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34 5.3 WHO guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34 5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35 6 Directions suggested by epidemiological modelling . . . . . .37 6.1 The impact of available interventions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37 6.2 Implications of an analysis of the TB and HIV epidemics . . . . . . . . . . . . . . . . .38 6.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40 7 Constraints and recommendations to overcome them . . .41 7.1 Planning and establishing an organizational framework at country level . .41 7.2 Advocacy and Information, Education & Communication . . . . . . . . . . . . . . . .42 7.3 Surveillance, monitoring and evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .42 7.4 Provision and improvement of clinical care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43 7.5 Scaling up joint activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .44 7.6 Summary of key recommendations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45 Annex 1 Meeting agenda . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .